Advertisement

Psychopharmacology

, Volume 225, Issue 3, pp 605–612 | Cite as

Docosahexaenoic acid-concentrated fish oil supplementation in subjects with mild cognitive impairment (MCI): a 12-month randomised, double-blind, placebo-controlled trial

  • Lai Kuan Lee
  • Suzana Shahar
  • Ai-Vyrn Chin
  • Noor Aini Mohd Yusoff
Original Investigation

Abstract

Rationale

Epidemiological studies have suggested a beneficial effect of fish oil supplementation in halting the initial progression of Alzheimer’s disease. However, it remains unclear whether fish oil affects cognitive function in older people with mild cognitive impairment (MCI).

Objectives

This study investigated the effects of fish oil supplementation on cognitive function in elderly person with MCI.

Methods

This was a 12-month, randomised, double-blind, placebo-controlled study using fish oil supplementation with concentrated docosahexaenoic acid (DHA). Thirty six low-socioeconomic-status elderly subjects with MCI were randomly assigned to receive either concentrated DHA fish oil (n = 18) or placebo (n = 18) capsules. The changes of memory, psychomotor speed, executive function and attention, and visual-constructive skills were assessed using cognitive tests. Secondary outcomes were safety and tolerability of the DHA concentrate.

Results

The fish oil group showed significant improvement in short-term and working memory (F = 9.890; ηp 2 = 0.254; p < 0.0001), immediate verbal memory (F = 3.715; ηp 2 = 0.114; p < 0.05) and delayed recall capability (F = 3.986; ηp 2 = 0.121; p < 0.05). The 12-month change in memory (p < 0.01) was significantly better in the fish oil group. Fish oil consumption was well tolerated, and the side effects were minimal and self-limiting.

Conclusions

This study suggested the potential role of fish oil to improve memory function in MCI subjects. Studies with larger sample sizes, longer intervention periods, different fish oil dosages and genetic determinations should be investigated before definite recommendations can be made.

Keywords

Fish oil Mild cognitive impairment Docosahexaenoic acid Cognitive function Memory 

Abbreviations

AD

Alzheimer’s disease

ADAS-cog

Cognitive section of the AD Assessment Scale

ANCOVA

Analysis of covariance

CDT

Clock drawing test

DHA

Docosahexaenoic acid

EPA

Eicosapentaenoic acid

GDS

Geriatric depression scale

MCI

Mild cognitive impairment

MMSE

Mini-mental state examination

PUFAs

Polyunsaturated fatty acids

RAVLT

Rey Auditory Verbal Learning Test

Notes

Acknowledgement

This work was supported by the Research University (grant number UKM-GUP-SK-07-21-041) grant scheme from the Universiti Kebangsaan Malaysia.

Disclosure statement

Both the fish oil and placebo capsules were provided by the EPAX AS, Lysaker, Norway. The authors have no conflicts of interest.

References

  1. Barberger-Gateau P, Raffaitin C, Letenneur L, Berr C, Tzourio C, Dartigues JF, Alpérovitch A (2007) Dietary patterns and risk of dementia: the Three-City cohort study. Neurology 69:1921–1930PubMedCrossRefGoogle Scholar
  2. Boston PF, Bennett A, Horrobin DF, Bennett CN (2004) Ethyl-EPA in Alzheimer’s disease—a pilot study. Prostaglandins Leukot Essent Fatty Acids 71:341–346PubMedCrossRefGoogle Scholar
  3. Calviello G, Serini S, Piccioni E (2008) Alzheimer’s disease and n−3 polyunsaturated fatty acids: beneficial effects and possible molecular pathways involved. Curr Signal Trans T 3:152–157CrossRefGoogle Scholar
  4. Chiu CC, Su KP, Chen TC, Liu HC, Chang CJ (2008) The effects of omega-3 fatty acids monotherapy in Alzheimer’s disease and mild cognitive impairment: a preliminary randomized double-blind placebo-controlled study. Prog Neuropsychopharmacol Biol Psychiatry 32:1538–1544PubMedCrossRefGoogle Scholar
  5. Cropley V, Croft R, Silber B, Neale C, Scholey A, Stough C, Schmitt J (2012) Does coffee enriched with chlorogenic acids improve mood and cognition after acute administration in healthy elderly? A pilot study. Psychopharmacology 219:737–749PubMedCrossRefGoogle Scholar
  6. Cunnane SC, Plourde M, Pifferi F, Féart C, Barberger-Gateau P (2009) Fish, docosahexaenoic acid and Alzheimer’s disease. Prog Lipid Res 48:239–256PubMedCrossRefGoogle Scholar
  7. Dangour AD, Allen E, Elbourne D, Fasey N, Fletcher AE, Hardy P, Holder GE, Knight R, Letley L, Richards M, Uauy R (2010) Effect of 2-y n-3 long-chain polyunsaturated fatty acid supplementation on cognitive function in older people: a randomized, double-blind, controlled trial. Am J Clin Nutr 91:1725–1732PubMedCrossRefGoogle Scholar
  8. Dullemeijer C, Durga J, Brouwer IA, Van de rest O, Kok FJ, Brummer RJM, Van Boxtel MPJ, Verhoef P (2007) n 3 fatty acid proportions in plasma and cognitive performance in older adults. Am J Clin Nutr 86:1479–1485PubMedGoogle Scholar
  9. Fagherazzi EV, Garcia VA, Maurmann N, Bervanger T, Halmenschlager LH, Busato SB, Hallak JE, Zuardi AW, Crippa JA, Schröder N (2012) Memory-rescuing effects of cannabidiol in an animal model of cognitive impairment relevant to neurodegenerative disorders. Psychopharmacology 219:1133–1140PubMedCrossRefGoogle Scholar
  10. Folch J, Lees M, Sloanes-Stanley JH (1957) A simple method for isolation and purification of total lipids from animal tissues. J Biol Chem 226:497–509PubMedGoogle Scholar
  11. Folstein MF, Folstein SE, McHugh PR (1975) Mini-Mental State: a practical method for grading the cognitive state of patients for the clinician. J Psychiatry Res 12:189–198CrossRefGoogle Scholar
  12. Fontani G, Corradeschi F, Felici A, Alfatti F, Migliorini S, Lodi L (2005) Cognitive and physiological effects of omega-3 polyunsaturated fatty acid supplementation in healthy subjects. Eur J Clin Invest 35:691–699PubMedCrossRefGoogle Scholar
  13. Freund-Levi Y, Eriksdotter-Jonhagen M, Cederholm T, Basun H, Faxén-Irving G, Garlind A, Vedin I, Vessby B, Wahlund L-O, Palmblad J (2006) Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: omegAD study: a randomized double-blind trial. Arch Neurol 63:1402–1408PubMedCrossRefGoogle Scholar
  14. Huang TL, Zandi PP, Tucker KL, Fitzpatrick AL, Kuller LH, Fried LP, Burke GL, Carlson MC (2005) Benefits of fatty fish on dementia risk are stronger for those without APOE epsilon4. Neurology 65:1409–1414PubMedCrossRefGoogle Scholar
  15. Kotani S, Sakaguchi E, Warashina S, Matsukawa N, Ishikura Y, Kiso Y, Sakakibara M, Yoshimoto T, Guo J, Yamashima T (2006) Dietary supplementation of arachidonic and docosahexaenoic acids improves cognitive dysfunction. Neurosci Res 56:159–164PubMedCrossRefGoogle Scholar
  16. Lee LK, Shahar S, Chin AV, Yusoff NAM, Rajab NF, Aziz S (2012a) Prevalence of gender disparities and predictors affecting the occurrence of mild cognitive impairment (MCI). Arch Gerontol Geriatr 54:185–191PubMedCrossRefGoogle Scholar
  17. Lee LK, Shahar S, Rajab N, Mohd Yusoff NA, Jamal RA, Then SM (2012b) The role of long chain omega-3 polyunsaturated fatty acids in reducing lipid peroxidation among elderly patients with mild cognitive impairment: a case–control study. J Nutr Biochem. doi: 10.1016/j.jnutbio.2012.04.014
  18. Lu P, Mamiya T, Lu LL, Mouri A, Ikejima T, Kim H-C, Zou L-B, Nabeshima T (2012) Xanthoceraside attenuates amyloid β peptide25–35-induced learning and memory impairments in mice. Psychopharmacology 219:181–190PubMedCrossRefGoogle Scholar
  19. Macpherson H, Ellis KA, Sali A, Pipingas A (2012) Memory improvements in elderly women following 16 weeks treatment with a combined multivitamin, mineral and herbal supplement. Psychopharmacology 220:351–365PubMedCrossRefGoogle Scholar
  20. Milte CM, Sinn N, Street SJ, Buckley JD, Coates AM, Howe PRC (2011) Erythrocyte polyunsaturated fatty acid status, memory, cognition and mood in older adults with mild cognitive impairment and healthy controls. Prostaglandins Leukot Essent Fatty Acids 84:153–161PubMedCrossRefGoogle Scholar
  21. Ng TP, Gao Q, Niti M, Feng L, Yap KB (2011) Omega-3 polyunsaturated fatty acid supplements and cognitive decline: Singapore longitudinal aging studies. JNHA 15:32–35Google Scholar
  22. Otsuka M (2000) Analysis of dietary factors in Alzheimer’s disease: clinical use of nutritional intervention for prevention and treatment of dementia. Nippon Ronen Igakkai Zasshi 37:970–973PubMedCrossRefGoogle Scholar
  23. Parker G, Gibson NA, Brotchi H, Heruc G, Rees A, Hadzi-Pavlovic D (2006) Omega-3 fatty acids and mood disorders. Am J Psychiatry 163:969–978PubMedCrossRefGoogle Scholar
  24. Petersen RC (2007) Mild cognitive impairment. Continuum Lifelong Learning Neurol 13:15–38Google Scholar
  25. Pomponi M (2008) DHA deficiency and Alzheimer’s disease. Clin Nutr 27:170PubMedCrossRefGoogle Scholar
  26. Quinn JF, Raman R, Thomas RG, Yurko-Mauro K, Nelson EB, Van Dyck C, Galvin JE, Emond J, Jack CR, Weiner M, Shinto L, Aisen PS (2010) Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial. JAMA 304:1903–1911PubMedCrossRefGoogle Scholar
  27. Rey A (1964) L’examen clinique en psychologie. In: Presses Universitaires de France. Paris (in French)Google Scholar
  28. Schaefer EJ, Bongard V, Beiser AS, Lamon-Fava S, Robins SJ, Au R, Tucker KL, Kyle DJ, Wilson PWF, Wolf PA (2006) Plasma phosphatidylcholine docosahexaenoic acid content and risk of dementia and Alzheimer disease: the Framingham Heart Study. Arch Neurol 63:1545–1550PubMedCrossRefGoogle Scholar
  29. Scholey A, Ossoukhova A, Owen L, Ibarra A, Pipingas A, He K, Roller M, Stough C (2010) Effects of American ginseng (Panax quinquefolius) on neurocognitive function: an acute, randomised, double-blind, placebo-controlled, crossover study. Psychopharmacology 212:345–356PubMedCrossRefGoogle Scholar
  30. Sheikh JI, Yesavage JA (1986) Geriatric Depression Scale: recent evidence and development of a shorter version. Clin Gerontol 5:165–173CrossRefGoogle Scholar
  31. Shinto L, Quinn J, Montine T, Baldauf-Wagner SB, Bourdette D, Oken DB, Kaye J (2008) Omega-3 fatty acids and lipoic acid in Alzheimer’s disease. Neurology 70:A393Google Scholar
  32. Sinn N, Milte CM, Street SJ, Buckley JD, Coates AM, Petkov J, Howe PRC (2012) Effects of n−3 fatty acids, EPA v. DHA, on depressive symptoms, quality of life, memory and executive function in older adults with mild cognitive impairment: a 6-month randomised controlled trial. Br J Nutr 107:1682–1693PubMedCrossRefGoogle Scholar
  33. Sonobe N, Hata R, Ishikawa T, Sonobe T, Matsumoto T, Toyota Y, Mori T, Fukuhara R, Komori K, Ueno SI, Tanimukai S, Ikeda M (2011) Risk of progression from mild memory impairment to clinically diagnosable Alzheimer’s disease in a Japanese community (from the Nakayama Study). Int Psychogeriatr 23:772–779CrossRefGoogle Scholar
  34. Sunderland T, Hill JL, Mellow AM, Lawlor BA, Gundersheimer J, Newhouse PA, Grafman JH (1989) Clock drawing in Alzheimer’s disease: a novel measure of dementia severity. J Am Geriatr Soc 37:725–729PubMedGoogle Scholar
  35. Van de Rest O, Geleijnse JM, Kok FJ, van Staveren WA, Dullermeijer C, Olderikkert MG, Beekman AT, de Groot CP (2008) Effect of fish oil on cognitive performance in older subjects: a randomized, controlled trial. Neurology 71:430–438PubMedCrossRefGoogle Scholar
  36. Wechsler D (1984) Wechsler memory scale—revised manual. The Psychological Co, New YorkGoogle Scholar
  37. Wechsler D (1997) Wechsler adult intelligence scale. Harcourt Assessment, LondonGoogle Scholar
  38. Whalley LJ, Deary IJ, Starr JM, Wahle KW, Rance KA, Bourne VJ, Fox HC (2008) n−3 Fatty acid erythrocyte membrane content, APOE epsilon4, and cognitive variation: an observational follow-up study in late adulthood. Am J Clin Nutr 87:449–454PubMedGoogle Scholar
  39. Yehuda S, Rabinovtz S, Carasso RL, Mostofsky DI (1996) Essential fatty acids preparation (SR-3) improves Alzheimer’s patients quality of life. Int J Neurosci 87:141–149PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2012

Authors and Affiliations

  • Lai Kuan Lee
    • 2
  • Suzana Shahar
    • 1
  • Ai-Vyrn Chin
    • 3
  • Noor Aini Mohd Yusoff
    • 4
  1. 1.School of Health Care Sciences, Faculty of Health SciencesUniversiti Kebangsaan MalaysiaKuala LumpurMalaysia
  2. 2.Nutrition Science Program, School of Health Care Sciences, Faculty of Health SciencesUniversiti Kebangsaan MalaysiaKuala LumpurMalaysia
  3. 3.Department of Geriatrics, Faculty of MedicineUniversiti MalayaKuala LumpurMalaysia
  4. 4.Faculty of Therapeutic SciencesMasterskill University College of Health SciencesCherasMalaysia

Personalised recommendations